Cellavision: Trend is still their friend

Research Update

2024-04-26

07:00

Redeye’s view on the Q1 report. The organic growth was decent, while the gross margin development comprised most of the deviation compared to the results. The cash flow was also strong. We have decreased our sales estimates and adjusted costs slightly for the coming years. We maintain our Base case of SEK 245 (245) and fair value range of SEK 160 – 380 per share

Mats Hyttinge

Analyst Q&A

Closed

Mats Hyttinge answered 3 questions.

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.